Meikle Phillip Terry II

Meikle Phillip Terry II is listed in filings as Director at Bone Biologics Corporation. This profile follows SEC Form 4 activity through Jun 6, 2025, including 6 public disclosures. Recent filings connect the profile to Bone Biologics Corporation (BBLGW) and Bone Biologics Corporation (BBLG). The current snapshot covers public activity from Oct 18, 2024 to Jun 6, 2025. Reported amounts are shown as $55.3K to $53.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.